基于《江苏省医疗机构药品遴选与临床应用评价体系》的氟维司群的临床综合评价研究

Clinical Comprehensive Evaluation Study of the Fulvestrant Based on the Index System for Drug Selection and Clinical Application Evaluation in Medical Institutions in Jiangsu Province

目的:对新型内分泌治疗药物氟维司群进行药品评价,为医疗机构遴选该药品提供参考。方法:参考药品说明书、临床指南、相关文献、权威数据平台和网站等,使用《江苏省医疗机构药品遴选与临床应用评价体系》的评价维度、评价细则及评价方法,对氟维司群进行药品量化评分与评价。结果:基于评价体系的氟维司群总评分为55分:其中,必要性8分,安全性6分,有效性20分,经济性5分,创新性3分,适宜性4分,可及性4分,其他情况5分。结论:本研究中所用方法可供医疗机构的药物遴选与评价参考,能够帮助医疗卫生机构快速地评价与遴选药品,可为临床用药提供参考。

Objective:To perform drug evaluation on the fulvestrant,so as to provide reference for medical institutions to select the drugs.Methods:With the reference to the drug inserts,clinical guidelines,relevant literature,authoritative data platforms and websites,the quantitative scoring and evaluation were conducted on the fulvestrant in a hospital by the evaluation and selection quantitative record form in the index system for drug selection and clinical application evaluation in medical institutions in jiangsu province.Results:the total score of fulvestrant was 55.Among them,8 points for necessity,6 points for safety,20 points for effectiveness,5 points for economy,3 points for innovativeness,4 points for suitability and 5 points for other indicators.Conclusion:The methods used in this study could be used as a reference for the selection of constipation drugs in hospitals,and also provide a basis for the rational selection of drugs in clinical practice,which can provide reference for clinical medication.